author-photo

Zheng (Jason) Yuan

Agios Pharmaceuticals

3

Papers

19

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers

2019 Clinical pharmacology in drug development
Show All
- Source
- Cite
- Save
Citations (14)
Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK Study

2016 Blood
Show All
- Source
- Cite
- Save
Citations (5)